The KRAS oncogene: Past, present, and future
- 25 November 2005
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1756 (2) , 81-82
- https://doi.org/10.1016/j.bbcan.2005.10.001
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Mouse models of K-ras-initiated carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
- Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung CancerCell, 2005
- RAS oncogenes: the first 30 yearsNature Reviews Cancer, 2003
- What is the origin of pancreatic adenocarcinoma?Molecular Cancer, 2003
- Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinomaGenes & Development, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in miceGastroenterology, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Kirsten ras Mutations in Patients With Colorectal Cancer: the Multicenter "RASCAL" StudyJNCI Journal of the National Cancer Institute, 1998
- Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.Proceedings of the National Academy of Sciences, 1982